Table 3.

Coefficients from conditional logistic regression among 65 HIV-positive women in the antepartum vs. postpartum periods

Benefits related to preventive therapy	Antepartum		Postpartum		p- value†
	Coefficient (SE)	95% CI	Coefficient (SE)	95% CI
Preventing HIV transmission	0.87 (0.14)**	(0.59, 1.15)	0.20 (0.09)*	(0.03, 0.38)	<0.01
Keeping healthy and working	0.41 (0.11)**	(0.19, 0.63)	0.10 (0.09)	(−0.07, 0.27)	0.02
Keeping healthy for family	0.75 (0.15)**	(0.45, 1.04)	0.05 (0.08)	(−0.09, 0.20)	<0.01
Keeping CD4 high	0.19 (0.10)	(−0.01, 0.40)	0.41 (0.10)**	(0.22, 0.59)	0.13
Keeping disease under control	0.67 (0.11)**	(0.46, 0.87)	0.24 (0.10)*	(0.04, 0.44)	0.01
Preventing infections	0.40 (0.12)**	(0.16, 0.64)	0.03 (0.10)	(−0.16, 0.22)	0.02
Preventing TB	0.44 (0.11)**	(0.23, 0.66)	0.21 (0.08)**	(0.05, 0.38)	0.10

^*P-values from Wald tests are reported: p-value <0.05;

^**p-value <0.01

^†P-values were estimated from the model where both antepartum and postpartum visits and the interaction terms between each benefit and timing of visits (postpartum vs. antepartum) were fitted in one model.